The results showed that compared to ST, QJHTD significantly reduced IL-6 in patients with stable COPD (MD = -4.33, 95% CI [-6.17, -2.48], p = 0.000, Fig 9). Here, IL6 is linked to chronic obstructive pulmonary disease.